4//SEC Filing
Shak Steven 4
Accession 0001209191-19-050246
CIK 0001131324other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:58 PM ET
Size
5.5 KB
Accession
0001209191-19-050246
Insider Transaction Report
Form 4
Shak Steven
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-09-17$71.47/sh−25,000$1,786,692→ 58,795 total(indirect: By Trust)
Footnotes (4)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2019.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $71.24 to $71.91.
- [F4]Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001337334
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:58 PM ET
- Size
- 5.5 KB